Last updated on November 2018

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis


Brief description of study

Phase 3 study to compare the efficacy of bimekizumab versus placebo in the treatment of subjects with moderate to severe chronic plaque psoriasis.

Clinical Study Identifier: NCT03410992

Contact Investigators or Research Sites near you

Start Over

UCB Cares

Ps0013 668
North Bay, Canada